CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-14 | Coulie Bernard President and CEO | Sale | −3,757 | $32.98 | $124K | 449,560 |
| 2021-06-14 | Coulie Bernard President and CEO | Sale | −243 | $33.69 | $8K | 449,317 |
| 2021-05-26 | Hull Hans Chief Business Officer | Exercise or conversion | +4,500 | $2.08 | $9K | 125,246 |
| 2021-05-26 | Hull Hans Chief Business Officer | Exercise or conversion · Stock Option (right to buy) | −4,500 | 12,979 | ||
| 2021-05-14 | Coulie Bernard President and CEO | Sale | −2,997 | $28.53 | $85K | 453,820 |
| 2021-05-14 | Coulie Bernard President and CEO | Sale | −503 | $29.28 | $15K | 453,317 |
| 2021-04-14 | Coulie Bernard President and CEO | Sale | −3,500 | $30.33 | $106K | 456,817 |
| 2021-04-13 | Coulie Bernard President and CEO | Exercise or conversion | +6,000 | $2.08 | $12K | 54,840 |
| 2021-04-13 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −6,000 | 337,380 | ||
| 2021-03-18 | Lefebvre Eric Chief Medical Officer | Sale | −11,365 | $39.38 | $448K | 150,715 |
| 2021-03-18 | Lefebvre Eric Chief Medical Officer | Sale | −1,135 | $39.78 | $45K | 149,580 |
| 2021-03-15 | Coulie Bernard President and CEO | Sale | −1,322 | $38.03 | $50K | 462,495 |
| 2021-03-15 | Coulie Bernard President and CEO | Sale | −2,000 | $38.75 | $78K | 460,495 |
| 2021-03-15 | Coulie Bernard President and CEO | Sale | −178 | $39.69 | $7K | 460,317 |
| 2021-03-05 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +20,000 | $2.08 | $42K | 47,621 |
| 2021-03-05 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −20,000 | 170,097 | ||
| 2021-02-16 | Coulie Bernard President and CEO | Sale | −1,200 | $32.10 | $39K | 466,117 |
| 2021-02-16 | Coulie Bernard President and CEO | Sale | −2,100 | $32.87 | $69K | 464,017 |
| 2021-02-16 | Coulie Bernard President and CEO | Sale | −200 | $34.07 | $7K | 463,817 |
| 2021-01-23 | Howes Barbara Chief Human Resource Officer | Grant or award · Stock Option (right to buy) | +42,500 | 42,500 |
Page 16 of 19 · 379 trades